Open Forum Infectious Diseases · 2022 · 26 citations · 28 references
Veterinary MedicineInfectious DiseasesMicrobiologyDiagnostic MicrobiologyInfectious Disease EpidemiologyMedical MicrobiologyHiv DiagnosisHiv EpidemiologyInfectious Disease ScreeningSexually Transmitted Infection EpidemiologySexually Transmitted Infection PreventionSexually Transmitted InfectionsAsymptomatic Sexually Transmitted InfectionsGenotypic Resistance ProfilingGenotypic Resistance TestingMacrolide TherapyMycoplasma Genitalium InfectionMycoplasma InfectionsNeisseria Gonorrhoeae ResistancePrimary Infection
Abstract Background Mycoplasma genitalium (Mg) is an emerging sexually transmitted pathogen among men who have sex with men (MSM). Resistance to recommended antimicrobial agents are of public health concern. Few data exist on Mg infections in MSM diagnosed with human immunodeficiency virus (HIV) during primary HIV infection. Methods Participants of the Zurich Primary HIV Study (ClinicalTrials.gov Identifier NCT 00537966) were systematically offered screening for sexually transmitted infections (STIs) between April 2019 and September 2020. Screening was performed using an in-house polymerase chain reaction panel comprising Mg including genotypic resistance testing for macrolides and quinolones, Chlamydia trachomatis including serovars L1-L3, Neisseria gonorrhoeae, Treponema pallidum, and Hemophilus ducreyi. Results We screened 148 of 266 (55.6%) participants, with an overall total of 415 follow-up visits. Ninety-one percent were MSM. The incidence rate for all STIs was 47.0 (95% confidence interval [CI], 32.2–68.6) per 100 person-years. Mycoplasma genitalium was the most frequently detected pathogen: 30 participants (20%) presented with at least 1 Mg infection, corresponding to a period prevalence of 20.3% and incidence rate of 19.5 Mg infections (95% CI, 11.8–32.4). Most Mg infections (93%) were asymptomatic, and 9 (30%) participants showed spontaneous clearance. We detected high rates of antibiotic resistance: 73.3% to macrolides, 3.3% to quinolones, and 13.3% resistance to both antibiotics. Conclusions The high prevalence of mostly asymptomatic Mg infections and high rate of spontaneous clearance support cautious initiation for treatment. The high proportion of macrolide-resistant strains suggests that a genotypic determination of resistance should be standard of care. Moxifloxacin should be the preferred treatment option for symptomatic Mg infections among MSM if resistance testing is unavailable.
28
Sexually Transmitted Diseases Treatment Guidelines, 2010
Kimberly Workowski, Gail Bolan · Annals of Emergency Medicine · 2011 · 2.1K citations · Full text
Jørgen Skov Jensen, Catriona S. Bradshaw, Sepehr N. Tabrizi et al. · Clinical Infectious Diseases · 2008 · 338 citations
Melanie Bissessor, Sepehr N. Tabrizi, Jimmy Twin et al. · Clinical Infectious Diseases · 2014 · 191 citations · Full text
Suneeta Soni, Paddy Horner, Michael Rayment et al. · International Journal of STD & AIDS · 2019 · 182 citations · Full text